{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:43:52Z","timestamp":1761057832116},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1097\/00000441-200008000-00007","type":"journal-article","created":{"date-parts":[[2003,11,10]],"date-time":"2003-11-10T11:10:36Z","timestamp":1068462636000},"page":"100-106","source":"Crossref","is-referenced-by-count":22,"title":["Current Medical Management of Secondary Hyperparathyroidism"],"prefix":"10.1016","volume":"320","author":[{"given":"Michael","family":"Yudd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Llach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/00000441-200008000-00007_bb0005","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1681\/ASN.V251014","article-title":"The effect of long term intravenous calcitriol administration on parathyroid function in hemodialysis patients","volume":"2","author":"Rodriguez","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1097\/00000441-200008000-00007_bb0010","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ki.1991.314","article-title":"Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol","volume":"40","author":"Rodriguez","year":"1991","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-200008000-00007_bb0015","series-title":"Nutrition and the kidney","first-page":"96","article-title":"Requirements for calcium, phosphorus, and vitamin D","author":"Massry","year":"1993"},{"key":"10.1097\/00000441-200008000-00007_bb0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1042\/cs0430519","article-title":"The effect of aluminum hydroxide on calcium, phosphorus and aluminum balances, the serum parathyroid hormone concentration and the aluminum content of bone in patients with chronic renal failure","volume":"43","author":"Clarkson","year":"1972","journal-title":"Clin Sci"},{"key":"10.1097\/00000441-200008000-00007_bb0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1172\/JCI113886","article-title":"Reduction of dietary phosphorus absorption by phosphorus binders","volume":"83","author":"Sheikh","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1097\/00000441-200008000-00007_bb0030","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ki.1989.247","article-title":"Calcium acetate, an effective phosphorus binder in patients with renal failure","volume":"36","author":"Mai","year":"1989","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-200008000-00007_bb0035","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI115317","article-title":"Intestinal absorption of magnesium from food and supplements","volume":"88","author":"Fine","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1097\/00000441-200008000-00007_bb0040","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(86)90987-6","article-title":"Substitution of aluminum salts by magnesium salts in control of dialysis hyperphosphatemia","volume":"i","author":"O\u2019Donovan","year":"1986","journal-title":"Lancet"},{"key":"10.1097\/00000441-200008000-00007_bb0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0272-6386(97)90009-3","article-title":"Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure","volume":"29","author":"Chertow","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1097\/00000441-200008000-00007_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0272-6386(12)80882-1","article-title":"Calcium and phosphorus fluxes during hemodialysis with a low calcium dialysate","volume":"18","author":"Hou","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1097\/00000441-200008000-00007_bb0055","first-page":"193","article-title":"Studies of phosphate removal in clinical dialysis [abstract]","volume":"25","author":"Shinaberger","year":"1984","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-200008000-00007_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/089686088300300213","article-title":"Comparison of control serum phosphate levels during continuous ambulatory peritoneal dialysis and during hemodialysis","volume":"3","author":"Cannata","year":"1983","journal-title":"Perit Dial Bull"},{"key":"10.1097\/00000441-200008000-00007_bb0065","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.V95859","article-title":"Nocturnal hemodialysis: three-year experience","volume":"9","author":"Pierratos","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1097\/00000441-200008000-00007_bb0070","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ki.1989.277","article-title":"Long term effects of calcium carbonato and 2.5mEq\/liter calcium dialysate on mineral metabolism","volume":"36","author":"Slatopolsky","year":"1989","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-200008000-00007_bb0075","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ki.1993.92","article-title":"Calcium kinetics and the long-term effects of lowering dialysate calcium concentration","volume":"43","author":"Argiles","year":"1993","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-200008000-00007_bb0080","series-title":"Brenner and Rector\u2019s the kidney","first-page":"2187","article-title":"Renal osteodystrophy","author":"Llach","year":"1996"},{"key":"10.1097\/00000441-200008000-00007_bb0085","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/ndt\/9.8.1207","article-title":"Successful treatment of massive uremic tumoral calcinosis with daily hemodialysis and very low calcium dialysate","volume":"9","author":"Fernandez","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/00000441-200008000-00007_bb0090","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1172\/JCI108424","article-title":"Comparison of effects of 1-\u03b1-hydroxyvitamin D3 and 1,25-dihydroxy-vitamin D3 in man","author":"Brickman","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1097\/00000441-200008000-00007_bb0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000403276","article-title":"Skeletal response to treatment with 1,25 dihydroxyvitamin D in renal failure","volume":"18","author":"Sherrard","year":"1980","journal-title":"Contrib Nephrol"},{"key":"10.1097\/00000441-200008000-00007_bb0100","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7326\/0003-4819-88-6-774","article-title":"1,25 dihydroxycholecalciferol effect in chronic dialysis. A double-blind controlled study","volume":"88","author":"Beri","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-200008000-00007_bb0105","series-title":"Vitamin D: chemical, biochemical and clinical endocrinology of calcium metabolism","first-page":"833","article-title":"Prospective, double blind trial with calcitriol in the prophylaxis of bone disease in asymptomatic dialysis patients","author":"Coburn","year":"1982"},{"key":"10.1097\/00000441-200008000-00007_bb0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1203\/00006450-197403000-00003","article-title":"Somatomedin and growth after renal transplantation","volume":"8","author":"Saenger","year":"1974","journal-title":"Pediatr Res"},{"key":"10.1097\/00000441-200008000-00007_bb0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ki.1987.176","article-title":"\u201cHigh dose\u201d calcitriol for control of renal osteodystrophy in children on CAPD","volume":"32","author":"Salusky","year":"1987","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-200008000-00007_bb0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200008000-00007_bb0125","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/ki.1993.377","article-title":"Intermittent versus continuous administration of 1,25(OH)2D3 in experimental renal hyperparathyroidism","volume":"44","author":"Reichel","year":"1993","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-200008000-00007_bb0130","first-page":"158","article-title":"Intravenous calcitriol for severe secondary hyperparathyroidism in dialysis patients [abstract]","volume":"27","author":"Norris","year":"1985","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-200008000-00007_bb0135","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ki.1989.305","article-title":"Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis patients","volume":"36","author":"Dunlay","year":"1989","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-200008000-00007_bb0140","first-page":"556A","article-title":"Two and a half year follow-up of intravenous calcitriol therapy for severe secondary hyperparathyroidism: Hyperphosphatemia and hypercalcemia","volume":"8","author":"Yudd","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1097\/00000441-200008000-00007_bb0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ndt\/11.supp3.96","article-title":"Guidelines for dosing intravenous calcitriol in dialysis patients with hyperphosphatemia","volume":"11","author":"Fernandez","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/00000441-200008000-00007_bb0150","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ki.1992.404","article-title":"Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Italian Group for the Study of Intravenous Calcitriol","volume":"42","author":"Gallieni","year":"1992","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-200008000-00007_bb0155","first-page":"1794","article-title":"Hyperphosphatemia worsened parathyroid function in dialysis patients with severe hyperparathyroidism who received intravenous calcitriol [abstract]","volume":"7","author":"Llach","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1097\/00000441-200008000-00007_bb0160","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-Dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1097\/00000441-200008000-00007_bb0165","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ki.1989.89","article-title":"1,25(0H)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia","volume":"35","author":"Szabo","year":"1989","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-200008000-00007_bb0170","first-page":"S62","article-title":"Parathyroidectomy in chronic renal failure: indications, surgical approach and the use of calcitriol","volume":"38","author":"Llach","year":"1990","journal-title":"Kidney Int"},{"key":"10.1097\/00000441-200008000-00007_bb0175","first-page":"895","article-title":"Ultrasonically guided fine-needle alcohol injection as an adjunct to medical treatment in secondary hyperparathyroidism","volume":"21","author":"Giangrande","year":"1984","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"10.1097\/00000441-200008000-00007_bb0180","first-page":"412","article-title":"Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism","volume":"17","author":"Giangrande","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/00000441-200008000-00007_bb0185","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ki.1994.373","article-title":"Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients","volume":"46","author":"Kitaoka","year":"1994","journal-title":"Kidney Int"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915349454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915349454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T18:45:25Z","timestamp":1623523525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915349454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S0002962915349454"],"URL":"https:\/\/doi.org\/10.1097\/00000441-200008000-00007","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}